Oppenheimer & Co. Inc. Buys 1,153 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Oppenheimer & Co. Inc. increased its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 0.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 204,354 shares of the company’s stock after purchasing an additional 1,153 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $3,237,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Karpus Management Inc. grew its holdings in BlackRock Health Sciences Term Trust by 14.9% during the 1st quarter. Karpus Management Inc. now owns 1,398,681 shares of the company’s stock valued at $22,924,000 after purchasing an additional 181,092 shares during the last quarter. Lazard Asset Management LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 24.3% in the first quarter. Lazard Asset Management LLC now owns 798,962 shares of the company’s stock worth $13,094,000 after buying an additional 156,417 shares during the period. B. Riley Wealth Advisors Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the first quarter worth approximately $285,000. Comerica Bank lifted its stake in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after acquiring an additional 3,671 shares during the last quarter. Finally, Register Financial Advisors LLC boosted its holdings in BlackRock Health Sciences Term Trust by 5,365.6% during the 2nd quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after acquiring an additional 6,707 shares during the period.

BlackRock Health Sciences Term Trust Trading Down 2.1 %

BMEZ stock opened at 15.26 on Friday. BlackRock Health Sciences Term Trust has a twelve month low of 13.53 and a twelve month high of 16.59. The business’s fifty day simple moving average is 15.78 and its two-hundred day simple moving average is 15.57.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a $0.1769 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 13.91%. The ex-dividend date of this dividend is Friday, November 15th.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. acquired 29,795 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Wednesday, October 16th. The stock was purchased at an average price of 15.81 per share, for a total transaction of 471,058.95. Following the purchase, the insider now directly owns 20,750,913 shares in the company, valued at 328,071,934.53. The trade was a 0.14 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders purchased a total of 99,630 shares of company stock worth $1,585,113 over the last 90 days.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.